Information for Authors

1. Overview

BRI is an academic open access company publishing peer reviewed journals. All articles published by BRI are made immediately available worldwide under an open access license. We are committed to providing high-quality and rapid publishing. Our aim is to fulfill the information needs of particular research communities worldwide, and maximize the dissemination of innovative research achievements.

BRI journals are the perfect place for you to publish your work under an open access license, in a fast and straightforward manner. Our journals are indexed in the leading databases and, since they are open access, have a broad readership.

Our mission is to make new research findings accessible to everyone. We are serving scholars from across the globe and from a variety of backgrounds. The key to our mission is that valuing differences, so that we can create an equitable and inclusive work environment and foster the openness.


2. Useful Resources for Authors

Reference Style & Template

Frontiers in Bioscience-Landmark

Frontiers in Bioscience-Scholar

Frontiers in Bioscience-Elite

Article Processing Charges (APC) Information

Policy Regarding Corrections and Retractions

Paper Promotion Tips


3. Manuscript Submission & Instructions for Authors

Frontiers in Bioscience-Landmark

Frontiers in Bioscience-Scholar

Frontiers in Bioscience-Elite


4. Discounts and Waivers for Authors

For authors from Low and Middle income countries, waivers or discounts may be granted on a case-by-case basis.


5. General Peer Review and Editorial Procedures

When you submit a manuscript to a BRI journal, your manuscript is evaluated in several stages. The Journal Editorial Office will perform an initial check of manuscript’s suitability and other general BRI requirements. Subsequently, a journal Editor will select appropriate experts for peer review and collect at least two critiques per manuscript. If necessary, we will ask authors for adequate revisions, with a second round of peer-review if necessary, before a final decision regarding publication is made. Apart from exceptional circumstances, we allow a maximum of two rounds of major revision per manuscript. The final decision is made by an academic editor (usually the Editor-in-Chief/Editorial Board Member of a journal or the Guest Editor of a Special Issue).

Anonymizing your manuscript

To facilitate effective double-blind peer review, authors must ensure that their manuscripts do not reveal their identities to reviewers.

• The title page will remain separate from the manuscript during peer review and will not be shown to the peer reviewers.

• Take care with the names of the files you upload, and anonymize the entire document in the “document properties”.

• Exclude any acknowledgements of funding sources in the title page which is not sent to the peer reviewers. Also use the title page to declare any conflicts of interest.

• Use third person voice to reference any of your own work.


6. Editor Decision and Revision

• Accept after Minor Revisions:

The paper is in principle accepted after revision based on the reviewer’s comments. Authors are given seven days for minor revisions.

• Reconsider after Major Revisions:

The acceptance of the manuscript will depend on the revisions made to the manuscript. Authors need to provide a point by point response or a rebuttal if some of the reviewer’s comments cannot be revised. Usually, only one round of major revisions is allowed. Authors will be asked to resubmit the revised paper within a suitable time frame, and the revised version will be returned to the reviewer for further comments.

• Reject and Encourage Resubmission:

If additional experiments are needed to support the conclusions, the manuscript will be rejected and the authors will be encouraged to re-submit the paper once further experiments have been conducted.

• Reject:

The article has serious flaws, and/or makes no original significant contribution. No offer of resubmission to the journal will be provided.


7. Copyright / Open Access

Starting from 2021, all BRI journals’ content is available online, and is fully browsable and searchable. All BRI journals papers are published as Open Access articles under the unrestrictive CC-BY license. The copyright is retained by the author(s).

BRI will insert the following note in the footer of the first page of the published text:

This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).

© 2021 The Authors. Published by BRI.

BRI has obtained the copyright of articles from Frontiers in Bioscience, Inc. which have been published from 1996 to January 2021.


8. Digital Preservation

BRI is committed to the permanent availability and preservation of scholarly research and to ensure accessibility by converting and upgrading digital file formats to comply with new and evolving technology standards.

BRI is part of IMR Press, who administers our manuscript archive. IMR Press is a participant in the CLOCKSS project, an international community initiative through which libraries and publishers work together to assure long-term preservation of their digital content. If content is no longer available from any participating publisher, then CLOCKSS will make this content available through open access.


9. Funded by the National Institute of Health (NIH)

National Institute of Health (NIH) requires all manuscripts accepted for publication on or after April 7, 2008 which report research, that is funded in whole or in part by the NIH, to be submitted into PubMed Central (PMC). If you are funded by NIH, we are happy to assist you in depositing the author's published version of your article in the repository PubMed Central.